|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Dr. Andrew Murphy is an Associate Professor at the Baker Heart and Diabetes Institute in Melbourne, Australia. He seeks to understand the processes by which hematopoietic stem cells and the bone marrow niche become affected in disease, specifically in the context of cardiovascular and metabolic disease. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Dr. Robert Mays is the co-founder and Vice President of Regenerative Medicine and Head of Neuroscience Programs at Athersys Inc, and an Adjunct Professor at the Case Western Reserve University School of Medicine. His paper in the Lancet Neurology discusses his Phase II clinical trial using multipotent adult progenitor cells as a therapy for acute stroke. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
